Brain Tunnelgenix Technologies Corp.
USPTO PatentsView assignee record - 29 granted patents across 13 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Brain ranks #10,563 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 13 technology areas.
- #10,563
- of 49,997 US assignees by volume
- Top 9%
- by Innovation Score (53.4/100)
- 14.8
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R10563 · US Corporation #10,563 · 29 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-SMALL 29 grants
- UPPER-Q #10,563/49,997
- PHOTO-FINISH Barclays Execution…
- CPC-FOCUS A61B · 13 areas
- INNOV-PAR 53.4/100
- CLAIMS-RICH 14.8 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2022–2025 · 4y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Barclays Execution Services Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Brain’s 53.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Brain
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Amicus Therapeutics · near
Amicus Therapeutics · near
53 score
- Brain Tunnelgenix · this assignee
Brain Tunnelgenix · this assignee
53 score
- Bridgestone Europe / · near
Bridgestone Europe / · near
53 score
- JFrog · near
JFrog · near
53 score
- Sogang University… · near
Sogang University… · near
53 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Brain's Innovation Score is 53.4/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Brain?
Each dot is one of Brain’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Brain’s own 14.8 claims/patent is ABOVE the 14.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Brain's grants concentrate
Brain Tunnelgenix Technologies Corp. is a focused PatentsView assignee: 13 CPC subclasses with 72.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (11 grants) versus a trough of 4 in 2022. By volume, Brain sits between Barclays Execution Services Limited and C4 Therapeutics, Inc..
Brain's three-year grant acceleration
Brain Tunnelgenix Technologies Corp. shows 20 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Brain's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Barclays Executio…
Barclays Execution Services Limited
29 patents
- Bear Robotics
Bear Robotics, Inc.
29 patents
- Blue Force Gear
Blue Force Gear, Inc.
29 patents
- Bote
Bote, LLC
29 patents
- British Broadcast…
British Broadcasting Corporation
29 patents
- C N R S
C.N.R.S.
29 patents
- C3 Nano
C3 Nano, Inc.
29 patents
- C4 Therapeutics
C4 Therapeutics, Inc.
29 patents
- Brain Tunnelgenix ◀
Brain Tunnelgenix Technologies Corp.
29 patents
What this shows Brain holds 29 patents at rank #10,564, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Brain
By rank, the assignees closest to #10,564 in granted patent volume.
- Barclays Execution Services Limited #10,560 · 29 patents
- Bear Robotics, Inc. #10,561 · 29 patents
- Blue Force Gear, Inc. #10,562 · 29 patents
- Bote, LLC #10,563 · 29 patents
- British Broadcasting Corporation #10,565 · 29 patents
- C.N.R.S. #10,566 · 29 patents
- C3 Nano, Inc. #10,567 · 29 patents
- C4 Therapeutics, Inc. #10,568 · 29 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Brain's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Brain, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Brain ranks #851 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (53 here).
Brain's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
53 Top 9% higher than 91% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 4 | 13.8% |
| 2023 | 5 | 17.2% |
| 2024 | 11 | 37.9% |
| 2025partial year | 9 | 31.0% |
Which technologies does Brain Tunnelgenix Technologies Corp. patent most?
Top 13 of 13 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Brain Tunnelgenix Technologies Corp.'s patent record in context - here's where to go next.
- Brain Tunnelgenix Technologies Corp.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 72.4% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #10,563 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Brain Tunnelgenix Technologies Corp. against Barclays Execution Services Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 53.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.